期刊文献+

带有不同亚型HPVL_1基因片段的哺乳动物细胞克隆的建立 被引量:1

Establishment of mammalian cell cloning with different subtype HPV L_1 gene fragment
下载PDF
导出
摘要 目的构建携带HPV亚型L1基因片段的标准细胞株。方法根据HPV通用引物GP5+/GP6+,用重叠延伸PCR方法合成HPV亚型L1基因中约150bp片段;插入真核细胞表达载体EGFPN1,用脂质体转染SPC细胞,筛选以获得带有不同HPVL1基因片段细胞克隆,并用定量PCR方法确认。结果重叠延伸PCR后得到约150bp的基因片段,测序结果经BLAST比对,分别与相应HPV亚型公开报告序列一致;将所获片段与EGFPN1载体连接后酶切及测序鉴定正确;经筛选获得了携带HPV6、11、16、18、31、35亚型L1基因片段的细胞株;并用定量PCR方法进行了确认。结论成功构建了带有不同HPV亚型L1基因片段的30个亚克隆和6个细胞株,为进一步的HPV分型检测研究提供了保证。 Objective To prepare the standard cell line involved clinical frequent HPV subtype L1 gene fragment. Methods According to HPV consensus primer GP5^+/GP6^+ , 150 bp gene fragment of each HPV subtype L1 gene was synthesized with the overlap extension PCR, recombined with PMD18-T vector and identified by enzymase digestion and sequencing. The recombinant was restructed with EGFP-N1 vector, transfected into SPC cell line, screened by G418 and identified by real-time PCR. Results A gene fragment about 150 bp was obtained by OE-PCR, and its DNA sequence was identical to public sequence of each subtype. Each recombinant plasmid was conjuncted with EGFP-N1 vector and confirmed by enzymase digestion and sequencing. Screened by G418, cell strains involving HPV6, 11, 16, 18, 31,35 L1 gene fragment were obtained and identified by real-time PCR. Conclusion The successful cloning of 30 clinical frequent HPV subtype LI gene fragments and construction of 6 cell strains have laid a foundation for the further studies on detection of HPV.
出处 《第三军医大学学报》 CAS CSCD 北大核心 2006年第5期469-471,共3页 Journal of Third Military Medical University
关键词 HPV 重叠延伸 GP5^+/GP6^+ 定量PCR HPV overlap-extension PCR GP5 ^+/GP6^+ quantitative PCR
  • 相关文献

参考文献9

  • 1BURD E M.Human papillomavirus and cervical cancer[J].Clin Microbiol Rev,2003,16(1):1 -17.
  • 2刘君,孙红.人类乳头状瘤病毒与宫颈癌[J].上海医学,2003,26(10):768-770. 被引量:2
  • 3BOSCH F X,LORINCZ A,MUNOZ N,et al.The causal relation between human papillomavirus and cervical cancer [J].J Clin Pathol,2002,55(4):244 -265.
  • 4MUNOZ N,BOSCH F X,DE SANJOSE S,et al.Epidemiologic classification of human papillomavirus types associated with cervical cancer [J].NEngl J Med,2003,348(6):518 -527.
  • 5DE RODA HUSMAN A M,WALBOOMERS J M,VAN DEN BRULE A,et al .The use of general primers GP5 and GP6 elongated at their 3' ends with adjacent highly conserved sequences improves human papillomavirus detection by PCR[J].J Gen Virol,1995,76(Pt 4):1057 - 1062.
  • 6GRAVITT P E,PEYTON C L,APPLE R J,et al .Genotyping of 27 human papillomavirus types by using L1 consensus pcr products by a single-hybridization,reverse line blot detection method[J].J Clin Microbiol,1998,36(10):3020-3027.
  • 7SZUHAI K,SANDHAUS E,KOLKMAN ULJEE S M,et al.A novel strategy for human papillomavirus detection and genotyping with SybrGreen and molecular beacon polymerase chain reaction [J].Am J Pathol,2001,159(5):1651 - 1660.
  • 8SPEICH N,SCHMITT C,BOLLMANN R,et al.Human papillomavirus (HPV) study of 2916 cytological samples by PCR and DNA sequencing:genotype spectrum of patients from the west German area [J].J Med Microbiol,2004,53(Pt 2):125 - 128.
  • 9OH T J,KIM C J,WOO S K,et al.Development and clinical evaluation of a highly sensitive DNA Microarray for detection and genotyping of human papillomaviruses [J].J Clin Microbiol,2004,42 (7):3272 - 3280.

二级参考文献12

  • 1Burd EM. Human papillomavirus and cervical cancer. Clin Microbiol Rev, 2003, 16: 1-17.
  • 2van der Graaf Y, Molijn A, Doomewaard H, et al. Human papillomavirus and the long-term risk of cervical neoplasia. Am J Epidemiol, 2002, 156: 158-164.
  • 3Munoz N, Bosch FX, de Sanjose S, et al. Epidemiologic classification of human papillomavirua types associated with cervical cancer. N Engl J Med, 2003, 348: 518-527.
  • 4Clifford Gm, Smith JS, Plummet M, et al. Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis. Br J Cancer, 2003, 88: 63-73.
  • 5Moreno V, Bosch FX, Munoz N, et al. Effect of oral contraceptives on risk of cervical cancer in women with human papillomavirus infection: the IARC multicentric case-control study.Lancet, 2002, 359:1085-1192.
  • 6Munoz N, Franceschi S, Bosetti C, et al. Role of parity and human papillomavirus in cervical cancer: the IARC multicentric case-control study. Lancet, 2002, 359: 1093-1101.
  • 7de Villiers EM. Relationship between steroid hormone contraceptives and HPV, cervical intraepithelial neoplasia and cervical carcinoma, lnt J Cancer,2003, 103: 705-708.
  • 8Bachtiary B, Obermair A, Dreier B, et al. Impact of multiple HPV infection on response to treatment and survival in patients receiving radical radiotherapy for cervical cancer. Int J Cancer,2002, 102: 237-243.
  • 9Mandelblatt JS, Lawrence WF, Womack SM, et al. Benefits and costs of using HPV testing to screen for cervical cancer. JAMA,2002, 287: 2372-2381.
  • 10Lehtinen M, Pawlita M, Zumbach K, et al. Evaluation of antibody response to human papillomavirus early proteins in women in whom cervical cancer developed 1 to 20 years later. Am J Obstet Gynecol, 2003, 188: 49-55.

共引文献1

同被引文献9

  • 1Chen D, Gould A, Mather M, et al. HBsAg-vectored DNA vaccines elicit concomitant protective responses to multiple CTL epitopes relevant in human disease [ EB/OL]. Nature Precedings, [ 2009-01-10]. http ://precedings. nature, com/documents/1910/version/1.
  • 2Haigh O, Guo H, Edgtton K, et al. Multiple copies of a tumo epitope in a recombinant hepatitis B surface antigen (HBsAg) vaccine enhance CTL responses, but not tumor protection [ J ]. Virology, 2007, 368 (2) : 363 -375.
  • 3Woo W P, Doan T, Herd K A, et al. Hepatitis B surface antigen vector delivers protective cytotoxic T-lymphocyte responses to disease-relevant foreign epitopes [ J ]. J Virol, 2006, 80 (8) :3975 - 3984.
  • 4Peters M G, Farias E, Colombo L, et al. Inhibition of invasion and metastasis by glypican-3 in a syngeneic breast cancer model [ J 1. Breast Cancer Res Treat, 2003, 80 (2) :221 - 232.
  • 5Xiang Y Y, Ladeda W, Fihnus J. Glypiean-3 expression is silenced in human breast cancer[ J ]. Oneogene, 2001,20 (50) :7408 - 7412.
  • 6Sung Y K, Hwang S Y, Farooq M, et al. Growth promotion of HepG2 hepatoma cells by antisense-mediated knockdown of glypican-3 is independent of insulin-like growth factor 2 signaling [ J ]. Exp Mgl Med, 2003, 35(4) :257 -262.
  • 7Nakatsura T, Komori H, Kubo T, et al. Mouse homologue of a novel human oncofetal antigen, glypican-3, evokes T-cell-mediated tumor rejection without autoimmune reactions in mice [ J]. Clin Cancer Res, 2004, 10(24) :8630 -8640.
  • 8Motomura Y, Senju S, Nakatsura T, et al. Embryonic stem cell-derived dendritic cells expressing glypican-3, a recently identified oncofetal antigen, induce protective immunity against highly metastatic mouse melanoma, B16-F10 [J]. Cancer Res, 2006, 66(4) : 2414 -2422.
  • 9谭虎,杨天德,粟永萍,艾国平,黄岚,陶军,刘晓宏,楼淑芬.修饰GLP2分泌性表达载体的构建及促增殖活性测定的实验研究[J].第三军医大学学报,2007,29(17):1650-1653. 被引量:3

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部